Our data showed that SLC12A5 is a novel oncogene that regulates proliferation, cell cycle progression, ER stress, PI3K/AKT/mTOR signaling, and resistance to ferroptosis in HCC. This evidence concerns the gene MTOR and hepatocellular carcinoma.